ENZ - ENZO BIOCHEM INC

0.3138
-0.068   -21.606%

Share volume: 4,123,861
Last Updated: 04-17-2025
Healthcare/Services – Health: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$0.38
-0.07
-0.18%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
32%
Profitability 2%
Dept financing 29%
Liquidity 75%
Performance 52%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
-35.95%
3 Months
-52.24%
6 Months
-72.95%
1 Year
-71.21%
2 Year
-87.65%
Key data
Stock price
$0.31
P/E Ratio 
0.00
DAY RANGE
$0.31 - $0.40
EPS 
-$0.29
52 WEEK RANGE
$0.25 - $1.28
52 WEEK CHANGE
-$71.21
MARKET CAP 
0.000
YIELD 
16.50%
SHARES OUTSTANDING 
51.458 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
06-12-2025
BETA 
1.25
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,486,716
AVERAGE 30 VOLUME 
$653,267
Company detail
CEO: Hamid Erfanian
Region: US
Website: enzo.com
Employees: 520
IPO year: 1980
Issue type: Common Stock
Market: NYSE
Industry: Healthcare/Services – Health
Sector: Services

Enzo Biochem, Inc. researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally.

Recent news